Conference Coverage

PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan


 

REPORTING FROM ACC 19

Pages

Recommended Reading

Immunotherapy’s cardiac effects require early monitoring, management
Clinician Reviews
Therapy ups breast cancer survivors’ cardiac risks
Clinician Reviews
SGLT2 inhibitors morph into HF drugs
Clinician Reviews
­­ADT harms likely limited to men with CV comorbidities
Clinician Reviews
Heart failure outcomes are worse in select HIV-infected individuals
Clinician Reviews
Infective endocarditis isn’t what it used to be
Clinician Reviews
Five pitfalls in optimizing medical management of HFrEF
Clinician Reviews
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
Clinician Reviews
FDA approves new valsartan generic
Clinician Reviews
FDA: Programmable heart failure device approved
Clinician Reviews

Related Articles